Null genotypes of gstm1 and gstt1 contribute to risk of cervical neoplasia: An evidence-based meta-analysis

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Gao, Lin Bo ^a   Pan, Xin Min ^a,b   Li, Li Juan ^a   Liang, Wei Bo ^a   Bai, Peng ^a   Rao, Li ^c   Su, Xiao Wei ^a   Wang, Tao ^a   Zhou, Bin ^a   Wei, Yong Gang ^c   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; ASIAN; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; ETHNICITY; EVIDENCE BASED MEDICINE; FEMALE; GENE EXPRESSION REGULATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEDICAL HISTORY; NULL ALLELE; RISK ASSESSMENT; UTERINE CERVIX CANCER; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; RISK; UTERINE CERVIX TUMOR;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PROTEIN BINDING; UTERINE CERVICAL NEOPLASMS;

EID: 79956344946     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020157     Document Type: Article

References (111)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Safaeian M, Solomon D, Castle PE, (2007) Cervical cancer prevention-cervical screening: science in evolution. Obstet Gynecol Clin North Am 34: 739-760, ix.
3. Herrington CS, (1999) Do HPV-negative cervical carcinomas exist?-revisited. J Pathol 189: 1-3.
4. Walboomers JM, Meijer CJ, (1997) Do HPV-negative cervical carcinomas exist? J Pathol 181: 253-254.
5. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
6. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, (2007) Human papillomavirus and cervical cancer. Lancet 370: 890-907.
7. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, et al. (2003) Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 14: 805-814.
8. Cancer. ICoESoC (2007) Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 120: 885-891.
9. Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, et al. (2007) Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 370: 1609-1621.
10. Jee SH, Lee JE, Park JS, (2003) Polymorphism of codon 72 of p53 and environmental factors in the development of cervical cancer. Int J Gynaecol Obstet 80: 69-70.
11. Magnusson PK, Sparen P, Gyllensten UB, (1999) Genetic link to cervical tumours. Nature 400: 29-30.
12. Hemminki K, Dong C, Vaittinen P, (1999) Familial risks in cervical cancer: is there a hereditary component? Int J Cancer 82: 775-781.
13. Magnusson PK, Gyllensten UB, (2000) Cervical cancer risk: is there a genetic component? Mol Med Today 6: 145-148.
14. Koushik A, Platt RW, Franco EL, (2004) p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 13: 11-22.
15. Jee SH, Won SY, Yun JE, Lee JE, Park JS, et al. (2004) Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis. Int J Gynaecol Obstet 85: 301-308.
16. Sousa H, Santos AM, Pinto D, Medeiros R, (2007) Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int J Mol Med 20: 731-741.
17. Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, et al. (2009) TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol 10: 772-784.
18. McIlwain CC, Townsend DM, Tew KD, (2006) Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25: 1639-1648.
19. Hayes JD, Pulford DJ, (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600.
20. Ketterer B, (1988) Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 202: 343-361.
21. Strange RC, Spiteri MA, Ramachandran S, Fryer AA, (2001) Glutathione-S-transferase family of enzymes. Mutat Res 482: 21-26.
22. Pearson WR, Vorachek WR, Xu SJ, Berger R, Hart I, et al. (1993) Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet 53: 220-233.
23. Webb G, Vaska V, Coggan M, Board P, (1996) Chromosomal localization of the gene for the human theta class glutathione transferase (GSTT1). Genomics 33: 121-123.
24. Hayes JD, Flanagan JU, Jowsey IR, (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45: 51-88.
25. Warwick A, Sarhanis P, Redman C, Pemble S, Taylor JB, et al. (1994) Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 15: 2841-2845.
26. Warwick AP, Redman CW, Jones PW, Fryer AA, Gilford J, et al. (1994) Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking. Br J Cancer 70: 704-708.
27. de Carvalho CR, da Silva ID, Pereira JS, de Souza NC, Focchi GR, et al. (2008) Polymorphisms of p53, GSTM1 and GSTT1, and HPV in uterine cervix adenocarcinoma. Eur J Gynaecol Oncol 29: 590-593.
28. Joseph T, Chacko P, Wesley R, Jayaprakash PG, James FV, et al. (2006) Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol 101: 411-417.
29. Sharma A, Sharma JK, Murthy NS, Mitra AB, (2004) Polymorphisms at GSTM1 and GSTT1 gene loci and susceptibility to cervical cancer in Indian population. Neoplasma 51: 12-16.
30. Singh H, Sachan R, Devi S, Pandey SN, Mittal B, (2008) Association of GSTM1, GSTT1, and GSTM3 gene polymorphisms and susceptibility to cervical cancer in a North Indian population. Am J Obstet Gynecol 198: 303 e301-306.
31. Sobti RC, Kaur S, Kaur P, Singh J, Gupta I, et al. (2006) Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India. Cancer Genet Cytogenet 166: 117-123.
32. Palma S, Novelli F, Padua L, Venuti A, Prignano G, et al. (2010) Interaction between glutathione-S-transferase polymorphisms, smoking habit, and HPV infection in cervical cancer risk. J Cancer Res Clin Oncol 136: 1101-1109.
33. Nishino K, Sekine M, Kodama S, Sudo N, Aoki Y, et al. (2008) Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer. J Obstet Gynaecol Res 34: 994-1001.
34. Niwa Y, Hirose K, Nakanishi T, Nawa A, Kuzuya K, et al. (2005) Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects. Gynecol Oncol 96: 423-429.
35. Kim JW, Lee CG, Park YG, Kim KS, Kim IK, et al. (2000) Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 88: 2082-2091.
36. Lee SA, Kim JW, Roh JW, Choi JY, Lee KM, et al. (2004) Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women. Gynecol Oncol 93: 14-18.
37. Settheetham-Ishida W, Yuenyao P, Kularbkaew C, Settheetham D, Ishida T, (2009) Glutathione S-transferase (GSTM1 and GSTT1) polymorphisms in cervical cancer in Northeastern Thailand. Asian Pac J Cancer Prev 10: 365-368.
38. Chen C, Madeleine MM, Weiss NS, Daling JR, (1999) Glutathione S-transferase M1 genotypes and the risk of squamous carcinoma of the cervix: A population-based case-control study. American Journal of Epidemiology 150: 568-572.
39. Sierra-Torres CH, Au WW, Arrastia CD, Cajas-Salazar N, Robazetti SC, et al. (2003) Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environmental and Molecular Mutagenesis 41: 69-76.
40. Song GY, Shao SL, song ZY, (2006) Association of single nucleotide polymorphism in glutathione S-transferase with susceptibility to cervical cancer. TumourJournal of the World 5: 192-194.
41. Zhou Q, Wang J, Shao S, Ma X, Ding L, (2006) The association between glutathione S-transferase M1, T1 polymorphisms and risk of cervical cancer. The study of the relationship between glutathione S-transferase M1, T1 genotypes and the risk of cervical cancer. Modem Preventive Medicine 33: 269-271.
42. Ma C, Liu Y, Lu X, Ma Z, (2009) Association between genetic polymorph ism of GSTM1 and susceptibility to cervical cancer in Uighur women in Xinjiang. Chin J Obstet Gynecol 44: 629-631.
43. Huang YK, Hsieh HC, Sun JA, Chao CF, Huang RL, et al. (2006) Genetic polymorphisms of phase I and phase II xenobiotic enzymes in human papillomavirus related lesion and cancer of the uterine cervix. Tzu Chi Medical Journal 18: 267-274+328.
44. Ueda M, Toji E, Nunobiki O, Izuma S, Okamoto Y, et al. (2008) Germline polymorphism of cancer susceptibility genes in gynecologic cancer. Human Cell 21: 95-104.
45. Goodman MT, McDuffie K, Hernandez B, Bertram CC, Wilkens LR, et al. (2001) CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 81: 263-269.
46. Agorastos T, Papadopoulos N, Lambropoulos AF, Chrisafi S, Mikos T, et al. (2007) Glutathione-S-transferase M1 and T1 and cytochrome P1A1 genetic polymorphisms and susceptibility to cervical intraepithelial neoplasia in Greek women. Eur J Cancer Prev 16: 498-504.
47. Agodi A, Barchitta M, Cipresso R, Marzagalli R, La Rosa N, et al. (2010) Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily. International Journal of Gynecological Cancer 20: 141-146.
48. Ueda M, Hung YC, Terai Y, Saito J, Nunobiki O, et al. (2005) Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis. Gynecologic Oncology 96: 736-740.
49. Sierra-Torres CH, Arboleda-Moreno YY, Orejuela-Aristizabal L, (2006) Exposure to wood smoke, HPV infection, and genetic susceptibility for cervical neoplasia among women in Colombia. Environ Mol Mutagen 47: 553-561.
50. Liu Y, Ma W, Liu Q, Yang T, Xu X, et al. (2009) Association between genetic polymorph ism of GSTM1, CYP2E1 and susceptibility to cervical cancer and its precancerous lesions in Uighur women in Xinjiang. Prog Obstet Gynecol 18: 840-843.
51. Song GY, Song ZY, Xu JP, Shao SL, (2008) Association of single nucleotide polymorphism in glutathione S-transferase-M1 with susceptibility to cervical cancer in Shanxi Province. Chinese Journal of Cancer Prevention and Treatment 15: 1054-1056.
52. Camargo MC, Mera R, Correa P, Peek RM Jr, Fontham ET, et al. (2006) Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 1674-1687.
53. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, et al. (2005) Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162: 201-211.
54. Gao LB, Pan XM, Li LJ, Liang WB, Zhu Y, et al. (2010) RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat [Epub ahead of print].
55. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
56. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
57. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
58. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
59. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
60. Norppa H, (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149: 309-334.
61. Hayes JD, Strange RC, (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61: 154-166.
62. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, et al. (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10: 1239-1248.
63. Winkelstein W Jr, (1977) Smoking and cancer of the uterine cervix: hypothesis. Am J Epidemiol 106: 257-259.
64. Winkelstein W Jr, Shillitoe EJ, Brand R, Johnson KK, (1984) Further comments on cancer of the uterine cervix, smoking, and herpesvirus infection. Am J Epidemiol 119: 1-8.
65. Winkelstein W Jr, (1990) Smoking and cervical cancer-current status: a review. Am J Epidemiol 131: 945-957; discussion 958-960.
66. Steckley SL, Pickworth WB, Haverkos HW, (2003) Cigarette smoking and cervical cancer: Part II: a geographic variability study. Biomed Pharmacother 57: 78-83.
67. Haverkos HW, Soon G, Steckley SL, Pickworth W, (2003) Cigarette smoking and cervical cancer: Part I: a meta-analysis. Biomed Pharmacother 57: 67-77.
68. Greenberg ER, Vessey M, McPherson K, Yeates D, (1985) Cigarette smoking and cancer of the uterine cervix. Br J Cancer 51: 139-141.
69. Sood AK, (1991) Cigarette smoking and cervical cancer: meta-analysis and critical review of recent studies. Am J Prev Med 7: 208-213.
70. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE, (1997) Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 89: 868-873.
71. Hoffmann D, Hoffmann I, (1997) The changing cigarette, 1950-1995. J Toxicol Environ Health 50: 307-364.
72. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, et al. (2000) Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 82: 1332-1338.
73. Kuper H, Adami HO, Boffetta P, (2002) Tobacco use, cancer causation and public health impact. J Intern Med 251: 455-466.
74. Nadais Rda F, Campaner AB, Piato S, Longo Galvao MA, dos Santos RE, et al. (2006) Langerhans' cells and smoking in intraepithelial neoplasia of the cervix. Gynecol Oncol 102: 356-360.
75. Lai R, Crevier L, Thabane L, (2005) Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14: 1784-1790.
76. White DL, Li D, Nurgalieva Z, El-Serag HB, (2008) Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol 167: 377-389.
77. Wang B, Huang G, Wang D, Li A, Xu Z, et al. (2010) Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol 53: 508-518.
78. Economopoulos KP, Sergentanis TN, (2010) GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer 46: 1617-1631.
79. Raimondi S, Botteri E, Iodice S, Lowenfels AB, Maisonneuve P, (2009) Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis. Mutat Res 670: 6-14.
80. Saadat M, (2006) Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 97: 505-509.
81. Chen B, Cao L, Zhou Y, Yang P, Wan HW, et al. (2010) Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiologic studies. Dig Dis Sci 55: 1831-1838.
82. Boccia S, La Torre G, Gianfagna F, Mannocci A, Ricciardi G, (2006) Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis 21: 115-123.
83. La Torre G, Boccia S, Ricciardi G, (2005) Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 217: 53-60.
84. Wang H, Zhou Y, Zhuang W, Yin YQ, Liu GJ, et al. (2010) Glutathione S-transferase M1 null genotype associated with gastric cancer among Asians. Dig Dis Sci 55: 1824-1830.
85. Sergentanis TN, Economopoulos KP, (2010) GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121: 195-202.
86. Sull JW, Ohrr H, Kang DR, Nam CM, (2004) Glutathione S-transferase M1 status and breast cancer risk: a meta-analysis. Yonsei Med J 45: 683-689.
87. Qiu LX, Yuan H, Yu KD, Mao C, Chen B, et al. (2010) Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects. Breast Cancer Res Treat 121: 703-708.
88. Vogl FD, Taioli E, Maugard C, Zheng W, Pinto LF, et al. (2004) Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 13: 1473-1479.
89. Egan KM, Cai Q, Shu XO, Jin F, Zhu TL, et al. (2004) Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol Biomarkers Prev 13: 197-204.
90. Gao Y, Cao Y, Tan A, Liao C, Mo Z, et al. (2010) Glutathione S-transferase M1 polymorphism and sporadic colorectal cancer risk: An updating meta-analysis and HuGE review of 36 case-control studies. Ann Epidemiol 20: 108-121.
91. Johns LE, Houlston RS, (2000) Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis. Mutagenesis 15: 399-404.
92. Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, et al. (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366: 649-659.
93. Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, et al. (2002) Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 156: 95-109.
94. Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, et al. (2002) Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23: 1343-1350.
95. Shi X, Zhou S, Wang Z, Zhou Z, (2008) CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 59: 155-163.
96. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD, (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4: 589-594.
97. Houlston RS, (1999) Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 8: 675-682.
98. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP, (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167: 759-774.
99. Ye Z, Song H, Higgins JP, Pharoah P, Danesh J, (2006) Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 3: e91.
100. Zhuo WL, Zhang YS, Wang Y, Zhuo XL, Zhu B, et al. (2009) Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses. Arch Med Res 40: 169-179.
101. Yang CX, Matsuo K, Wang ZM, Tajima K, (2005) Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J Gastroenterol 11: 2531-2538.
102. Ntais C, Polycarpou A, Ioannidis JP, (2005) Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14: 176-181.
103. Mo Z, Gao Y, Cao Y, Gao F, Jian L, (2009) An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 69: 662-688.
104. Zhuo X, Cai L, Xiang Z, Li Q, Zhang X, (2009) GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res 28: 46.
105. Hashibe M, Brennan P, Strange RC, Bhisey R, Cascorbi I, et al. (2003) Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 12: 1509-1517.
106. Zhuo W, Wang Y, Zhuo X, Zhu Y, Wang W, et al. (2009) CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses. Cancer Invest 27: 86-95.
107. Varela-Lema L, Taioli E, Ruano-Ravina A, Barros-Dios JM, Anantharaman D, et al. (2008) Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med 10: 369-384.
108. Zhuo WL, Wang Y, Zhuo XL, Zhu B, Zhu Y, et al. (2009) Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses. J Cancer Res Clin Oncol 135: 1081-1090.
109. Das P, Shaik AP, Bammidi VK, (2009) Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia. Leuk Lymphoma 50: 1345-1351.
110. Ye Z, Song H, (2005) Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer 41: 980-989.
111. Economopoulos KP, Choussein S, Vlahos NF, Sergentanis TN, (2010) GSTM1 polymorphism, GSTT1 polymorphism, and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer 20: 1576-1580.